// App-Quantinova.ai

P227 : Outcomes of anti-TNF versus Vedolizumab therapy for ulcerative colitis: the Leeds experience

Researchers

Presenter

  • M.V. Lenti

Principal Investigators

  • A. Johnston

  • A. O'Connor

  • C. Selinger

  • A.C. Ford

  • P.J. Hamlin

Medical Centers

  • Leeds Gastroenterology Institute, Leeds Teaching hospitals, United Kingdom

  • Tallaght Hospital, Dublin, Ireland

  • University of Leeds, Leeds, United Kingdom

Locations

  • United Kingdom

  • Ireland

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • C reactive protein

Drug/Treatment

  • Entyvio

  • Infliximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved